Metraipolis › archive › dc_ca097c13ffb1
Long-term safety of Credelio Quattro™ (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets), a novel orally administered combination… — Europe PMC PMID:41398970
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41398970
- DOI
- 10.1186/s13071-[numero omesso]-3
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T15:28:33.355Z
- SHA-256 of the archived text
549a6ab24284411474d8ab8b1ce2083546e5eb154c5e8cedba03abc208da33d0- Stable URL of this page
https://metraipolis.com/documento/dc_ca097c13ffb1
How to cite
Long-term safety of Credelio Quattro™ (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets), a novel orally administered combination… — Europe PMC PMID:41398970 — Europe PMC (en), https://europepmc.org/article/MED/41398970 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ca097c13ffb1 (Metraipolis archive dc_ca097c13ffb1, sha256 549a6ab24284411474d8ab8b1ce2083546e5eb154c5e8cedba03abc208da33d0)
BibTeX
@misc{dcca097c13ffb1,
title = {Long-term safety of Credelio Quattro™ (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets), a novel orally administered combination… — Europe PMC PMID:41398970},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41398970},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ca097c13ffb1; sha256 549a6ab24284411474d8ab8b1ce2083546e5eb154c5e8cedba03abc208da33d0},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41398970. Agents can read the archived copy with the MCP tool read_document.